Hope for kids with rare disease: new drug trial targets dizziness and fainting
Symptom relief
Recruiting now
This study tests a drug called Northera (droxidopa) in children aged 7 to 17 with Menkes disease who still have symptoms like dizziness, fainting, and low blood pressure. The goal is to see if the drug is safe and can improve these symptoms and quality of life. About 6 to 10 chil…
Phase: PHASE1, PHASE2 • Sponsor: Stephen G. Kaler • Aim: Symptom relief
Last updated Apr 29, 2026 15:04 UTC